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In 2015, the American Board of Toxicology (ABT), with collaboration from the Society of Toxicology (SOT),
in consultation with Professional Examination Service, performed a practice analysis study of the
knowledge required for general toxicology. The purpose of this study is to help assure that the exami-
nation and requirements for attainment of Diplomate status are relevant to modern toxicology and based
upon an empirical foundation of knowledge. A proﬁle of the domains and tasks used in toxicology
practice was developed by subject-matter experts representing a broad range of experiences and per-
spectives. An on-line survey of toxicologists, including Diplomates of the ABT and SOT members,
conﬁrmed the delineation. Results of the study can be used to improve understanding of toxicology
practice, to better serve all toxicologists, and to present the role of toxicologists to those outside the
profession. Survey results may also be used by the ABT Board of Directors to develop test speciﬁcations
for the certifying examination and will be useful for evaluating and updating the content of professional
preparation, development, and continuing education programs.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The science of toxicology is advancing at a record pace, where
new knowledge increases daily. With advances in our under-
standing of the toxicity of new materials like nano-sized particles
coupled with the use of new technologies involved in high-
throughput screening, genomics, and adverse pathway analysis,
the manner and methods scientists use to determine mechanisms
and effect levels are constantly changing. Along with these changes
comes the need to be able to understand and utilize the advancing
science as a professional within the toxicology discipline.
The American Board of Toxicology (ABT), the largest profes-
sional toxicology credentialing organization in the world, strives to
identify, maintain, and evolve a standard for professional compe-
tency in the ﬁeld of toxicology. It is the vision of ABT to establish a
globally recognized credential in toxicology that represents com-
petency and commitment to human health and the environmentaly; DABT, Diplomates of the
Board of Toxicology Board of
ciety of Toxicology.
Inc. This is an open access article usciences. The purpose of ABT is to: 1) encourage the study and
science of toxicology, 2) stimulate advancement in the ﬁeld of
toxicology by establishing standards of practice and keeping these
standards current with advances in toxicology, and 3) confer
recognition upon members of the profession who, when measured
against such standards, demonstrate competence in the science
and practice of toxicology.
The ﬁrst ABTexamwas administered on August 4,1980 resulting
in the certiﬁcation of 217 Diplomates (Rinehart, 2000). Today there
are approximately 2300 certiﬁed Diplomates of the American
Board of Toxicology (DABT) world-wide. The beneﬁts of attaining
Diplomate status indicate that certiﬁcation in toxicology continues
to play an important role in employment opportunity, compensa-
tion, and professional advancement (Gad and Sullivan, 2016).
As mentioned, the science of toxicology is undergoing
continued advancements in knowledge and techniques since the
inception of professional certiﬁcation by American Board of Toxi-
cology. In order to assess these changes and evolve accordingly, the
ABT Board of Directors (BoD) has embarked upon an evaluation of
the current practice and standard of knowledge of toxicology
relevant to the evolution of toxicology in the twenty-ﬁrst century.
The purpose of this analysis is to help assure that the exami-
nation and requirements for attainment of Diplomate status arender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ical foundation of knowledge. To this end, the ABT BoD has taken
the steps presented here to ensure that these requirements and the
testing content of the ABT exam reﬂect the knowledge required in
the professional practice of toxicology and comply with the stan-
dards and recommendations outlined by the National Commission
for Certifying Agencies (NCCA) standards (National Commission for
Certifying Agencies, 2014).
2. Methods
2.1. Selection of the Practice Analysis Task Force
The ABT BoD, together with the Society of Toxicology (SOT),
selected a 10-member Practice Analysis Task Force (PATF). In
determining the composition of the PATF, key stakeholders from
the ABT BoD and SOT leadership considered critical demographic
and professional background variables such that the toxicologists
selected to serve on the PATF represented the diversity of toxi-
cology in practice settings and roles. Three members of the PATF
held the DABT credential and seven did not. Members of the PATF
are listed in Table 1.
The PATF was charged with the following activities over the
course of the study:
 Develop an initial model or organizational structure describing
general toxicology practice and delineate the tasks performed in
practice;
 Review and incorporate the work of the additional subject-
matter experts (SMEs) contributing to various qualitative data
collection initiatives;
 Develop survey rating scales and a demographic and profes-
sional questionnaire for the quantitative survey of toxicologists;
and
 Review the data obtained via the survey to create the ﬁnal
delineation of practice.
The PATF was responsible for developing the delineation of
domains and tasks of general toxicologists. In a process-based
description of practice, the work performed by professionals is
organized into domains, which are themajor areas of responsibility
that make up the role of a toxicologist. Domains encompass all ofTable 1
Members of the Practice Analysis Task Force (PATF), thought leaders, and independent r
PATF Thought leaders
Myrtle Davis, PhD., DVM
National Cancer Institute
Melvin E. Anderson, PhD.
The Hamner Institutes fo
Yvonne Dragan, PhD.
Haskell Labs
Linda Birnbaum, PhD., DA
National Institute of Envi
Jodi A. Flaws, PhD.
University of Illinois
Jack H. Dean, PhD., DABT
University of Arizona
Jeff Fowles, PhD.
CA Dept. of Public Health
Lois Lehman-McKeeman,
Bristol-Myers Squibb Com
Michael Holsapple, PhD., ATS
Michigan State University
Lewis B. Kintera, PhD., DABT
AstraZeneca Pharmaceuticals
Serrine Lau, PhD.
University of Arizona
David Mayﬁeld, MS., DABT
Gradient
E. Spencer Williams, PhD.
Baylor University
Adam Woolley, DABT, FRCPath, ERT, ATS
ForthTox Limited
a Currently with Green Lawn Professional Scientiﬁc Consulting.the tasks performed in practice. Tasks are the distinct, identiﬁable,
and speciﬁc job-related activities performed in the course of work
in the profession of toxicology.
Professional Examination Service (ProExam; New York, NY) is a
recognized expert in the development, implementation, and eval-
uation of credentialing programs, including the conduct of practice
analysis studies and the development of test speciﬁcations on
which to base credentialing program activities. The ABT BoD con-
tracted with ProExam to conduct the practice analysis study of
general toxicologists in order to develop and validate a process-
based delineation of the competencies of general toxicologists.
2.2. Task force meetings
ProExam facilitated eight two-hour virtual meetings of the PATF
over the course of the study. ProExam provided introductory ma-
terials (for the ﬁrst meeting) or the current iteration of the delin-
eation to be discussed (for subsequentmeetings) and a brief agenda
outlining the meeting goals for each virtual meeting. After each
meeting, the work output was distributed to PATF members for
comment and review; email feedback was circulated among PATF
members for consideration at each subsequent meeting.
The PATF developed the delineation through this iterative pro-
cess, working from an initial model developed during the ﬁrst two
meetings. The domain structure and tasks were reﬁned and
augmented during subsequent meetings based on input from
subject matter experts, as well as feedback received from the
complementary data collection initiatives described below and the
results of a pilot test of the on-line survey.
2.3. Thought leader interviews
ProExam conducted telephone interviews with four thought
leaders in the toxicology professionwhowere selected to represent
key perspectives in practice (Table 1). These thought leaders
responded to a series of questions under a protocol designed to
elicit information about major trends in the profession, recent and
anticipated changes in the roles andwork functions of toxicologists,
and the impact of these changes on the competencies and knowl-
edge base required of general toxicologists. Thought leaders also
commented on the delineation of practice and provided feedback
on the domain structure and tasks. The PATF reviewed the feedbackeviewers.
Independent reviewers
, DABT
r Health Sciences
Desmond I. Cannon, PhD., DABT
US Army Institute of Public Health
BT, ATS
ronmental Health Sciences
Janet Clarke, PhD., DABT
Newid Consulting
Jamie DeWitt, PhD.
East Carolina University
PhD, ATS
pany
Janice Lansita, PhD., DABT
ToxStrategies, Inc.
John Snawder, PhD., DABT
CDC-NIOSH
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delineation during the course of the meetings.2.4. Independent review
After the initial PATF meetings and the thought leader in-
terviews had been completed, ProExam circulated the delineation
of domains and tasks to ﬁve additional external SMEs for an inde-
pendent review. The members of the independent review panel
were selected by the ABT BoD to be representative of the toxicology
profession, and are listed in Table 1. ProExam compiled all feedback
and comments, and the PATF reviewed the results and further
reﬁned the delineation of practice.2.5. Survey development and rating scales
The delineation was uploaded into an on-line survey platform
for validation. Rating scales were used to enable survey re-
spondents to rate the elements of the delineation and to collect
data about the respondents via a professional and demographic
questionnaire.2.5.1. Tasks
Two rating scales were used by respondents to evaluate the
tasks, one designed to assess the respondents own work patterns
(Frequency) and the other designed to assess the task in the context
of the work of toxicologists in general (Importance). The frequency
with which each task was performed as part of a respondent's job
was rated on a 5-point scale with the following choices: never,
rarely, occasionally, frequently, or very frequently. Values used to
calculate mean importance of each task used a 4-point scale which
included the following: not, minimally, moderately, or highly
important.2.5.2. Domains
Two rating scales were used by respondents to evaluate the
domains. One assessed the percentage of work time during the past
12 months spent performing the tasks in each domain and the
other assessed the importance of the tasks in each domain to an
individual's work as a toxicologist. Five response options were
included on the importance scale for domains: 1¼ never, 2¼ rarely,
3 ¼ occasionally, 4 ¼ frequently, or 5 ¼ very frequently.2.5.3. Feedback on the delineation
As a check on the completeness of the delineation, respondents
answered one quantitative and two qualitative questions:
dHow completely did the delineation represent the work of
toxicologists in general?
dAre there any other tasks you perform in your work as a
toxicologist that were not included in the survey?
dPlease provide any other feedback you may have regarding
the delineation of toxicology practice.Table 2
Survey response rate.
ABT SOT Total
Invitations sent 2285 500 2785
Undeliverable (invalid email addresses) 93 2 95
Valid invitations 2192 498 2690
Completed surveys 961 98 1059
Response rate 43.8% 19.7% 39.4%2.6. Pilot test of the survey
The survey was pilot-tested in June 2015. Eleven external pilot
testers, members of the Task Force, and the ABT BoD and SOT
president were invited to review the online survey. Based on their
comments, a number of tasks were modiﬁed, one was moved to a
different sub-domain, and the rating scales and demographic
questionnaire were ﬁnalized.2.7. Survey dissemination
The large-scale validation survey was launched in mid-July 2015
and was open for three weeks. All 2285 certiﬁed DABTs were
included in the survey invitation list, and a random sample of 500
non-DABT members of SOT were also invited to participate. ABT
and SOT sent pre-survey emails to all invitees, and followed upwith
an invitation containing a unique link. Additional reminders were
sent over the course of the survey.
3. Results
3.1. Demographics
One thousand ﬁfty-nine respondents completed the survey, for
an overall response rate of nearly 40%. Approximately 44% of DABTs
and nearly 20% of the SOTmembers completed the survey (Table 2).
Fig. 1 summarizes the demographics of survey respondents. Re-
spondents had a mean of 21 years of experience as a toxicologist,
with 16% having less than 10 years, 32% having 11e20 years, and
27% having 21e30 years of experience. Eighty-four percent of re-
spondents held a doctoral degree, 12% a master's level degree, and
3% a bachelor's level degree. Overall, the largest percentage of re-
spondents (45%) worked in industry, followed by 12% in academia,
11% in independent consulting, 10% for the federal government and
8% in consulting for a ﬁrm. The primary area of practice for the
largest percentage of total respondents was pharmaceutical (41%)
followed by regulatory (13%) and academic (11%). Sixty-two
percent indicated they currently specialized in general toxicology,
49% in regulatory toxicology, and 43% in risk assessment.
Seventy-nine percent of respondents were from the United
States, representing 42 states or territories, and 21% were from
outside the US, representing 27 countries. The greatest number of
non-US respondents were from Canada (41), followed by India (32).
3.2. Delineation of toxicology
The delineation of the practice of general toxicology developed
by the PATF is shown in Table 3. As a result of the iterative devel-
opment process, the delineation was organized into a domain
structure consisting of six domains, one of which has four related
sub-domains, and includes 66 tasks and 3 sub-tasks.
Respondents indicated how completely they thought the
delineation represented the work of toxicologists. These responses
further validated that the domain structure developed over the
course of this study well represented the work of general toxicol-
ogists. As shown in Fig. 2, 91% of respondents thought the delin-
eation completely or mostly did so.
3.2.1. Highlights related to the tasks
Summary responses for the respondents rating of each task
under each domain were calculated for Frequency and Importance
as shown in Table 3.
Five of the 66 tasks/3 subtasks were performed at least weekly
(mean 4.0). Themost frequently performed taskwas Interpret and
Fig. 1. Background Information on work experience, area of employment, areas of toxicology practice, and education level.
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conclusions and/or inform next step (mean ¼ 4.2 ± 1.0); the next
most frequently performed task was Characterize, describe and
interpret effects and test system endpoints of toxicological concern
(mean ¼ 4.1 ± 1.2).
Seven of the tasks achieved mean frequency ratings below a
mean of 2.0, indicating they are performed less than monthly. The
least frequently performed tasks were Use population-based bio-
monitoring studies to ascertain temporal trends in chemical exposures
(mean ¼ 1.5 ± 0.9) and Develop or provide treatment recommenda-
tions for poisoning incidents (including antidotes) (mean ¼ 1.5 ± 1.0).
Despite not all tasks being performed frequently, all tasks were
rated highly important relative to the importance scale used in the
analysis. Twenty-nine tasks achieved mean ratings of 3.5 or higher,
meaning they were between moderately and highly important. The
most highly rated task on this scale was also the one rated highest
in frequency: Interpret and integrate study results into a scientiﬁcally
cogent narrative to develop conclusions and/or inform next steps
(mean importance ¼ 3.9 ± 0.4). Five tasks had mean importance
ratings of 3.8 including: Design scientiﬁcally valid studies to answer
questions or address deﬁned hypotheses (±0.5); Characterize toxico-
logical effects in vivo (±0.5); Characterize, describe and interpret ef-
fects and test system endpoints of toxicological concern (±0.4);
Identify systemic effects and/or target organs, dose response, and
thresholds of effect (±0.5); and Quantitatively and/or qualitatively
characterize relationships between dose (or concentration) and inci-
dence and severity of health effects or toxicological endpoint (±0.5).
Only three tasks were rated as less than moderately important
to the work of toxicologists, however, all three achieved a mean
rating of 2.9. These were Characterize toxicological effects in silico
(±0.8); Use differential mechanistic information to develop products
(±0.8); and Use population-based biomonitoring studies to ascertain
temporal trends in chemical exposures (±0.5).
A careful review of the write-in responses to the question
regardingmissing tasks found that in general, respondents wrote in
tasks that were either speciﬁc examples of existing tasks, unique
to their own work, not germane to their role as a toxicologist, orknowledge-based rather than task-based. The PATF did not ﬁnd any
suggestions that would warrant inclusion of any additional tasks in
the delineation based on these responses.
3.2.2. Highlights related to the domains
Table 4 shows the mean survey responses to the questions of
percentage of time spent in each domain, as well as the importance
rating of each domain. The delineated domain structure was
overwhelmingly validated by the indication that a signiﬁcant per-
centage of the respondents' toxicology work timewas spent in each
domain, and that all domains were at least moderately to highly
important to professional toxicologists.
The domain in which respondents spent the most time was Risk
Assessment (34% of time), followed by Design, Execute, and Interpret
Toxicology Studies (26%). Respondents spent the least amount of
time in Applied Toxicology: Public, Environmental, and Occupational
Health and Contribution to the Profession (both about 8%). Review of
the write-in responses to the question of time spent in other non-
delineated domains found that most such time was related to
managerial/administrative duties or to educational activities. No
write-in responses indicated that a domain was missing from the
structure.
The domain ranked as being most important to toxicologists in
general was Design, Execute, and Interpret Toxicology Studies
(mean ¼ 4.1 ± 1.1). Two sub-domains in the Risk Assessment
domain, Hazard Identiﬁcation and Dose Response Assessment, were
next most important (mean ¼ 4.0 ± 1.0 for both).
4. Discussion
The ﬁeld of toxicology is a matrixed one that integrates chem-
istry, biochemistry and physics into various levels of biological or-
ganization that span from molecular and cell biology to tissue,
organism, population, community and, ultimately, biosphere level
effects. It strives to understand the importance of exposure to
various chemical and biological stressors in a complex environment
in which science continues to make signiﬁcant advances.
Table 3
Delineations of general toxicology with mean Frequency and Importance ratings.
Domains and tasks Frequency
(5-pt scale)
Importance
(4-pt scale)
I. Design, Execute, and Interpret Toxicology Studies
1. Design scientiﬁcally valid studies to answer questions or address deﬁned hypotheses. 3.5 3.8
2. Comply with applicable regulations and guidelines speciﬁc to the agent under study. 3.9 3.7
3. Select and characterize the chemical and physical identity of the test agent. 2.5 3.1
4. Characterize toxicological effects in vivo. 3.8 3.8
5. Characterize toxicological effects in vitro. 3.1 3.5
6. Characterize toxicological effects in silico. 2.3 2.9
7. Characterize toxicological effects in a ﬁeld or clinical setting. 2.3 3.3
8. Develop, qualify, and validate new testing methods and techniques. 2.3 3.2
9. Analyze test results and integrate existing data using informatics, statistics, and modeling. 3.3 3.4
10. Interpret and integrate study results into a scientiﬁcally cogent narrative to develop conclusions and/or inform next steps. 4.2 3.9
11. Prepare research report or summary that is ﬁt for purpose. 4.0 3.7
II. Descriptive Toxicology: Environmental, Clinical, Non-clinical, and Forensic Investigations
1. Analyze and integrate toxicology data obtained from diverse sources to identify toxicological patterns of concern (molecules,
cells, tissues, target organs, individuals, populations, communities, ecosystems).
3.7 3.7
2. Identify hazards, risks, and putative mechanisms. 3.8 3.7
3. Develop strategies to test hypotheses. 3.2 3.5
4. Perform weight of evidence analyses. 3.4 3.5
5. Develop strategies to mitigate toxicity. 3.0 3.3
6. Translate results of descriptive toxicological investigations between species. 3.5 3.6
III. Mechanistic Toxicology
1. Develop mechanistic hypotheses. 2.8 3.3
2. Assess role of toxicokinetics in mechanism of toxicity. 3.3 3.5
3. Assess role of toxicodynamics in mechanism of toxicity. 3.1 3.4
4. Identify susceptibility factors. 2.8 3.2
5. Distinguish direct and indirect action. 3.1 3.3
6. Use differential mechanistic information to develop products. 2.1 2.9
7. Translate results between mechanistic studies and toxicological outcomes, prevention, and clariﬁcation of risk (human,
environmental, animal).
3.1 3.5
8. Develop and apply mechanistic information to disease models. 2.4 3.0
9. Apply principles of systems toxicology. 2.9 3.2
IV. Risk Assessment
A. Hazard Identiﬁcation
1. Characterize, describe and interpret effects and test system endpoints of toxicological concern - including but not limited to
acute and repeat dose toxicity, reproductive effects, genotoxicity, carcinogenicity, local effects/tolerance, and ecotoxicology
4.1 3.8
2. Apply appropriate test systems and study types for safety evaluation. 3.7 3.7
3. Identify systemic effects and/or target organs, dose response, and thresholds of effect. 4.0 3.8
4. Assess mechanisms of action and relevance to humans or other target species, including sensitive sub-populations and individuals. 3.6 3.6
5. Identify toxicological endpoints using the actual route, or appropriate surrogate of primary exposure. 3.7 3.6
B. Exposure Assessment
6. Select appropriate endpoints with which to document exposure to toxicants in test systems and populations. 3.3 3.5
7. Assess toxicant exposure in the general public, occupationally exposed individuals, populations, and the environment using
appropriate technologies (including but not limited to analytical, bioassay, biomonitoring).
2.3 3.3
8. Assess relevance of biomarkers of exposure in individuals, populations and the environment. 2.5 3.2
9. Characterize absorption (A), disposition (D), metabolism (M), excretion (E), and kinetics (PK or TK) of toxicants.” 2.9 3.5
10. Assess and document behavior, fate, and transport of chemicals entering the environment (for example, biotransformation,
bioavailability, bioaccumulation, biomagniﬁcation).
2.1 3.1
11. Consider issues of disproportional, unique, and reactive metabolites arising in speciﬁc species. 2.6 3.2
12. Identify primary and secondary interactions between agents and biological systems. 2.6 3.1
13. Assess impact of target and off-target interactions on cellular, tissue, organ, organism, population, and environmental functions. 2.9 3.3
C. Dose Response Assessment
14. Quantitatively and/or qualitatively characterize relationships between dose (or concentration) and incidence and severity of
health effects or toxicological endpoint.
3.9 3.8
15. Analyze toxicity data to determine a safe dose (or concentration) or protective threshold (for example, benchmark dose). 3.7 3.7
16. Analyze toxicity data to determine an effective or toxic dose (or concentration). 3.7 3.7
D. Risk Characterization and Management
17. Integrate toxicity and exposure information to characterize potential health risks and margins of safety. 3.7 3.7
18. Assess health risks and management options to protect environmental or public health (including but not limited to cleanup
goals, emission limits, safe concentrations, efﬁcacious concentrations).
2.4 3.3
a. Evaluate and implement alternatives to reduce risks. 2.3 3.1
b. Derive safety limits that are protective of environmental or public health. 2.5 3.4
c. Identify and implement emergency risk management options to reduce chemical exposures or risks. 1.8 3.0
V. Applied Toxicology: Public, Environmental, and Occupational Health
1. Characterize, describe and interpret effects of toxicological and ecotoxicological concern e in individuals, populations,
communities, and ecosystems.
2.4 3.4
2. Identify critical effects and thresholds from dose-response assessment. 3.0 3.5
3. Respond to public health issues, including new or emerging public health concerns. 2.1 3.2
4. Assess public health impacts from ecosystem effects of environmental toxicants. 1.7 3.1
5. Investigate health outcomes in speciﬁc groups with respect to measured or modeled chemical exposures. 1.9 3.1
6. Use population-based biomonitoring studies to ascertain temporal trends in chemical exposures. 1.5 2.9
7. Identify sensitive or susceptible subpopulations. 2.2 3.2
8. Design or implement programs to reduce the exposure to hazardous substances. 1.8 3.0
9. Evaluate products and communicate potential environmental, health, or safety issues (including product stewardship). 2.5 3.3
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Table 3 (continued )
Domains and tasks Frequency
(5-pt scale)
Importance
(4-pt scale)
10. Evaluate the safety or risk of toxic agents for the treatment of diseases (including but not limited to drug development). 2.7 3.5
11. Evaluate the signs and symptoms of toxicity. 3.2 3.5
12. Develop or provide treatment recommendations for poisoning incidents (including antidotes). 1.5 3.1
VI. Contribution to the Profession
1. Perform work in accordance with regulatory guidance and good laboratory practice standards (as applicable). 4.0 3.7
2. Improve regulatory guidelines to ensure guidelines reﬂect current scientiﬁc advances. 2.6 3.4
3. Provide testimony about toxic agents and products. 1.8 3.0
4. Communicate the results of toxicological or risk evaluations to technical, governmental, or public groups (including but
not limited to publications (peer reviewed and otherwise), technical reports, summary documentation (reviews), abstracts,
presentations and posters).
3.4 3.6
5. Establish, facilitate, or support programs to educate the public on environmental or public health issues. 2.0 3.2
6. Provide education, training, and mentorship for students, colleagues, and others in the ﬁeld. 3.2 3.4
7. Respond to requests from organizations (companies, government/regulatory authorities, scientiﬁc societies) for technical
expertise and comments about toxins/toxicants.
2.9 3.3
8. Disseminate information to trainees, colleagues, management, and appropriate organizations. 3.4 3.3
9. Incorporate new approaches to toxicology by using emerging technologies. 2.7 3.3
10. Participate in professional scientiﬁc or not-for proﬁt organizations. 3.5 3.3
Frequency of tasks rated on a 5-point scale: 1¼ Never/Not applicable to my job, 2¼ Rarely (less than once per month), 3¼ Occasionally (at least once per month), 4¼ Frequently (at
least once per week), 5 ¼ Very frequently (at least daily).
Importance of tasks rated on a 4-point scale: 1 ¼ Not important, 2 ¼ Minimally important, 3 ¼ Moderately important, 4 ¼ Highly important.
Table 4
Domains of toxicology: Percentage of time spent and the importance of each.
Domains % Of time
spent
Mean importance
(5-point scale)
I. Design, Execute, and Interpret Toxicology 26.4% 4.1
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stay current with these advances and the need to understand what
qualiﬁcations are necessary to conduct such work is a moving
target.
One of the guiding principles of the ABT is to assure that
advancement in the ﬁeld of toxicology is based upon sound stan-
dards of practice. Keeping these standards current in a dynamic
professional environment presents an important and ever-evolving
challenge to the ABT BoD.With this review and analysis, ABT strives
to serve Diplomates, employers, and the profession of toxicology as
a whole by systematically acquiring insights from science thought
leaders, practicing toxicologists, and other reviewers with interests,
expertise and experience in toxicology. It is not surprising that the
results are indicative of an evolving profession. The ABT BoD is
committed to using these results to continue the role of estab-
lishing certiﬁcation standards that are commensurate with evolu-
tion of the ﬁeld. Use and implementation of the data generated by
this effort are entirely at the discretion of the ABT BoD.
This survey will have a signiﬁcant impact on the design and
construction of the ABT certiﬁcation examination. One of the pri-
mary goals of the practice analysis study was the development of
test speciﬁcations for the ABTcertiﬁcation program using data from
the survey to generate the preliminary test speciﬁcations. The
analysis indicated the percentage of the examination that should
focus on content related to each domain. The empirically-derived
test speciﬁcations developed via this process are shown in
Table 5. Using this test speciﬁcation, the two domains of Risk
Assessment and Design, Execute, and Interpret Toxicology StudiesFig. 2. Assessment of delineation for representing the work of toxicologists.would make up slightly greater than 60% of the ABT certiﬁcation
examination.
However, ABT will ﬁrst consider whether any adjustments to
these data-derived test speciﬁcations are warranted. For those in-
dividuals just meeting eligibility requirements for the examination,
not all validated tasks in the delineation may be suitable for in-
clusion. For example, some of the tasks in Domain VI. Contribution to
the Profession (e.g., follow regulatory guidance, communicate with
the public or disseminate information, and be a mentor), may be
beyond what the toxicologist would be expected to be responsible
for at the point of certiﬁcation.
In response to a series of questions regarding information about
major trends in the profession and the impact of these changes on
the competencies and knowledge required by general toxicologists,
the emphasis was on a broad knowledge basewith fundamentals in
cell biology and physiology and the ability to work in teams. While
in vivo animal testing remains one of the major tools to evaluate
potential toxicities of a given agent, increased importance of
cellular and mechanistic studies, alternative animal models, and
high technology areas such as “omics” are perceived. Increased
interest was also noted in assessment of combinations of stressorsStudies
II. Descriptive Toxicology: Environmental,
Clinical, Non-clinical, and Forensic
Investigations
11.7% 3.6
III. Mechanistic Toxicology 8.5% 3.5
IV. Risk Assessment (Total, A through D) 33.7%
A. Hazard Identiﬁcation 11.1% 4.0
B. Exposure Assessment 6.9% 3.7
C. Dose Response Assessment 8.3% 4.0
D. Risk Characterization and Management 7.4% 3.8
V. Applied Toxicology: Public, Environmental,
and Occupational Health
8.0% 3.4
VI. Contribution to the Profession 8.4% 3.5
Other 3.3% 2.8
Total 100.0%
Importance of domains rated on a 5-point scale: 1 ¼ never, 2 ¼ rarely,
3 ¼ occasionally, 4 ¼ frequently, or 5 ¼ very frequently.
Table 5
Test speciﬁcations.
Domain % Of exam
I. Design, Execute, and Interpret Toxicology Studies 28.8%
II. Descriptive Toxicology: Environmental, Clinical, Non-clinical,
and Forensic Investigations
11.7%
III. Mechanistic Toxicology 8.5%
IV. Risk Assessment (Total, A through D) 34.8%
A. Hazard Identiﬁcation 11.5%
B. Exposure Assessment 7.0%
C. Dose Response Assessment 8.6%
D. Risk Characterization and Management 7.7%
V. Applied Toxicology: Public, Environmental, and
Occupational Health
8.1%
VI. Contribution to the Profession 8.1%
TOTAL 100.0%
C.S. Wood et al. / Regulatory Toxicology and Pharmacology 82 (2016) 140e146146and chemicals, and exposure issues relating to low doses and
sensitive subpopulations. The ABT BoD will use this information to
identify gaps in the existing evaluation process. These may include
evaluating the current database of questions, updating question
writing practices based upon empirically-derived test speciﬁca-
tions for the examination, and transitioning to an online system for
banking examination questions.
These empirically-derived test speciﬁcations may serve as the
starting point for evolution of the certiﬁcation examination, and
can be adjusted (i.e., have percentage allocations increased or
decreased) based on a number of factors. Such factors include but
are not limited toB:
 The number of tasks in each domain;
 If tasks within a domain are time consuming or repetitive, and
do not require a wide range of competencies or knowledge, so
that test items might be redundant;
 If there is overlap across domains (so as not to overweight some
areas of practice);
 If the characteristics of the sample population may have inﬂu-
enced the ratings; The potential or difﬁculty for developing test questions related
to the tasks in each domain;
 The suitability of the task for developing test questions for
candidates just meeting the eligibility requirements for the
certiﬁcation; and
 If the domain included emerging areas of practice.
The American Board of Toxicology continues its dedication to
serve the public and practice of toxicology world-wide. With these
analyses, it is the intent of the ABT BoD to continue its progress in
service and dedication to the science of toxicology, those who
devote their professional lives to that science, and the employers
who expect excellence from Diplomates of the American Board of
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